Patent · US Active

Method for RGEN RNP delivery using 5′-phosphate removed RNA

US10767174B2 · kind B2 · utility

1Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2016
Grant dateSep 8, 2020
Priority date
Expiry dateNov 10, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a composition for ribonucleoprotein delivery, comprising a guide RNA free of 5′-terminal phosphates, and a method for ribonucleoprotein delivery, using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.